Teva- Pharmaceutical Industries Overview
Teva- Pharmaceutical Industries Target Price
Analysts' average 12-month price target for Teva- Pharmaceutical Industries is $45.
Get informed when a big investor buys or sells
+ FollowShare Price
$36.76
Average Target Price
$44.67
21.5% upside
21.5% upside3 analysts in the last 4 months
High: $48 | Low: $42
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-09-04 | UBSAshwani Verma | $48 | 30.6% upside |  |
| 2026-08-12 | Barclays | $42 | 14.3% upside | |
| 2026-07-28 | Piper SandlerDavid Amsellem | $44 | 19.7% upside | |
| 2026-05-06 | Barclays | $40 | 8.8% upside | |
| 2026-04-30 | Piper Sandler | $42 | 14.3% upside | |
| 2026-04-30 | UBS | $42 | 14.3% upside | |
| 2026-03-04 | Piper SandlerDavid Amsellem | $41 | 11.5% upside | |
| 2026-01-30 | BarclaysGlen Santangelo | $38 | 3.4% upside | |
| 2026-01-29 | Scotiabank | $40 | 8.8% upside | |
| 2026-01-07 | Truist Financial | $36 |  2.1% downside | |
| 2026-01-06 | Jefferies | $40 | 8.8% upside | |
| 2025-12-22 | Piper Sandler | $40 | 8.8% upside | |
| 2025-12-18 | Goldman Sachs | $35 | 4.8% downside | |
| 2025-12-08 | Barclays | $35 | 4.8% downside | |
| 2025-12-04 | Scotiabank | $35 | 4.8% downside | |
| 2025-11-06 | Goldman SachsMatt Dellatorre | $28 | 23.8% downside | |
| 2024-12-18 | UBSAshwani Verma | $28 | 23.8% downside | |
| 2024-12-18 | BarclaysBalaji Prasad | $28 | 23.8% downside | |
| 2024-10-23 | BarclaysBalaji Prasad | $25 | 32% downside | |
| 2024-10-01 | Bank of America SecuritiesJason Gerberry | $22 | 40.2% downside | |
| 2024-09-03 | UBSAshwani Verma | $26 | 29.3% downside | |
| 2024-08-28 | Piper SandlerDavid Amsellem | $23 | 37.4% downside | |
| 2024-08-01 | BarclaysBalaji Prasad | $22 | 40.2% downside | |
| 2024-07-10 | Argus ResearchJasper Hellweg | $20 | 45.6% downside | |
| 2024-07-10 | UBSAshwani Verma | $24 | 34.7% downside | |
| 2024-06-05 | BarclaysBalaji Prasad | $21 | 42.9% downside | |
| 2024-05-23 | BarclaysBalaji Prasad | $20 | 45.6% downside | |
| 2024-05-13 | Piper SandlerDavid Amsellem | $20 | 45.6% downside | |
| 2024-02-12 | Piper SandlerDavid Amsellem | $19 | 48.3% downside | |
| 2024-01-23 | JefferiesGlen Santangelo | $14 | 61.9% downside | |
| 2022-11-14 | J.P. Morgan | $10 | 72.8% downside | |
| 2022-06-13 | UBSAshwani Verma | $10 | 72.8% downside | |
| 2022-05-04 | Piper Sandler | $7 | 81% downside | |
| 2022-04-20 | BarclaysBalaji Prasad | $13 | 64.6% downside | |